+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

T Cell Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

T Cell Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Advanced Antibodies, 2020 - Product Thumbnail Image

Advanced Antibodies, 2020

  • Report
  • December 2020
  • 39 Pages
  • Global
From
From
HPV Associated Disorders Global Market Report 2024 - Product Thumbnail Image

HPV Associated Disorders Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Advanced Cervical Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Cervical Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 160 Pages
  • Global
From
From
Immuno-Oncology - Thematic Research - Product Thumbnail Image

Immuno-Oncology - Thematic Research

  • Report
  • May 2022
  • 167 Pages
  • Global
From
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
From
From
Ovarian Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Ovarian Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
Fallopian tube cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Fallopian tube cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator